A Phase 1 Dose Escalation Study of GC4419 in Combination With Chemoradiation for Squamous Cell Cancer of the Head & Neck
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Aftab Mahmood, MD
Cancer Specialists of South Texas, P.A.
Principal Investigator - Charles Kunos, MD, PhD
Summa Health System- Cooper Cancer Center
Principal Investigator - Christopher M Lee, MD
Cancer Care Northwest
Principal Investigator - Douglas Adkins, MD
Washington University School of Medicine
Principal Investigator - John Buatti, MD
University of Iowa
Principal Investigator - Jon T. Holmlund, MD
Galera Therapeutics, Inc.
Study Director - Larisa Greenberg, MD
West Penn Allegheny Health System
Principal Investigator - Madhavi Venigalla, MD
Lakeland Regional Cancer Center
Principal Investigator - Marcelo Bonomi, MD
Wake Forest University Health Sciences
Principal Investigator - Pardip Pathare, MD
Norwalk Hospital
Principal Investigator - Sanjiv Agarwala, MD
St. Luke's Cancer Center
Principal Investigator - Weining Zhen, MD
University of Nebraska
Principal Investigator - Yuhchyau Chen, MD, PhD
University of Rochester
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Lakeland Regional Cancer Center
Lakeland, Florida, United States
- University of Iowa
Iowa City, Iowa, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- University of Nebraska Medical Center
Omaha, Nebraska, United States
- University of Rochester Medical Center
Rochester, New York, United States
- Wake Forest Baptist Health
Winston-Salem, North Carolina, United States
- Summa Health System- Cooper Cancer Center
Akron, Ohio, United States
- St. Luke'S Cancer Center
Easton, Pennsylvania, United States
- Allegheny General Hospital
Pittsburgh, Pennsylvania, United States
- Cancer Care Northwest
Spokane, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2013
- Primary completion
- 31 Jul 2015
- Completion
- 31 Aug 2016
- Last update posted
- 22 Sept 2016
- Registered enrollment
- 30
- Registry id
- NCT01921426
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.